Theriva Biologics, Inc. Common Stock Shares Outstanding

• Theriva Biologics, Inc. showed an increase of +1,182.6% in Common Stock Shares Outstanding from 2024 to 2025.
• This data is from Theriva Biologics, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
• XBRL data for this metric is available from 2010 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 20 years of available data (2010 to 2025), Theriva Biologics, Inc.'s Common Stock Shares Outstanding has grown by 52.9%.
• Historical annual values: Fiscal year 2025: 35.69 million shares | Fiscal year 2024: 2.78 million shares | Fiscal year 2024: 1.01 million shares | Fiscal year 2023: 686,219 shares | Fiscal year 2022: 15.12 million shares | Fiscal year 2022: 15.84 million shares | Fiscal year 2022: 15.84 million shares | Fiscal year 2022: 15.84 million shares | Fiscal year 2021: 13.20 million shares | Fiscal year 2020: 29.25 million shares | Fiscal year 2019: 16.81 million shares | Fiscal year 2018: 15.48 million shares | Fiscal year 2017: 3.67 million shares | Fiscal year 2016: 117.17 million shares | Fiscal year 2015: 90.83 million shares | Fiscal year 2014: 72.51 million shares | Fiscal year 2013: 58.21 million shares | Fiscal year 2012: 44.36 million shares | Fiscal year 2011: 31.29 million shares | Fiscal year 2010: 23.34 million shares.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026